Paradice Investment Management LLC Has $22.55 Million Holdings in LivaNova PLC (NASDAQ:LIVN)

Paradice Investment Management LLC boosted its position in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 15.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 486,821 shares of the company's stock after purchasing an additional 64,680 shares during the quarter. LivaNova comprises 4.5% of Paradice Investment Management LLC's holdings, making the stock its 11th biggest position. Paradice Investment Management LLC owned 0.90% of LivaNova worth $22,545,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Central Pacific Bank Trust Division increased its stake in shares of LivaNova by 21.2% in the 4th quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company's stock valued at $191,000 after acquiring an additional 720 shares during the last quarter. Captrust Financial Advisors bought a new stake in shares of LivaNova in the 3rd quarter valued at about $217,000. Sanctuary Advisors LLC bought a new stake in shares of LivaNova in the 3rd quarter valued at about $219,000. Edgestream Partners L.P. bought a new stake in shares of LivaNova in the 3rd quarter valued at about $244,000. Finally, GSA Capital Partners LLP bought a new stake in shares of LivaNova in the 3rd quarter valued at about $292,000. 97.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other LivaNova news, Director Francesco Bianchi sold 1,250 shares of the company's stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $50.99, for a total transaction of $63,737.50. Following the completion of the transaction, the director now owns 7,522 shares of the company's stock, valued at $383,546.78. This represents a 14.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.27% of the company's stock.

LivaNova Stock Down 1.1 %

NASDAQ:LIVN traded down $0.55 during trading hours on Friday, reaching $47.44. 493,509 shares of the stock were exchanged, compared to its average volume of 451,341. LivaNova PLC has a twelve month low of $43.15 and a twelve month high of $64.47. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The firm has a 50 day moving average of $48.04 and a 200 day moving average of $49.53. The stock has a market cap of $2.58 billion, a PE ratio of 112.95 and a beta of 1.00.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on LIVN shares. Mizuho lowered their price target on LivaNova from $80.00 to $70.00 and set an "outperform" rating for the company in a research note on Thursday, October 31st. Needham & Company LLC reissued a "buy" rating and set a $75.00 target price on shares of LivaNova in a research note on Tuesday, January 28th. Robert W. Baird increased their target price on LivaNova from $66.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday, October 31st. Finally, StockNews.com raised LivaNova from a "buy" rating to a "strong-buy" rating in a research note on Friday, February 14th. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, LivaNova presently has an average rating of "Buy" and an average price target of $69.17.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.